373 related articles for article (PubMed ID: 15362775)
21. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis.
Ren Y; Poon RT; Tsui HT; Chen WH; Li Z; Lau C; Yu WC; Fan ST
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5996-6001. PubMed ID: 14676125
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor receptor-1 levels in hepatocellular carcinoma and correlations with clinicopathological features.
Yolcu OF; Köklü S; Yüksel O; Coban S; Ayaz S; Akif Oztürk M; Benekli M
Hepatogastroenterology; 2007; 54(77):1526-8. PubMed ID: 17708290
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma.
Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Ono K; Kubo S
J Hepatobiliary Pancreat Surg; 2006; 13(3):239-44. PubMed ID: 16708302
[TBL] [Abstract][Full Text] [Related]
25. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma.
Poon RT; Lau CP; Ho JW; Yu WC; Fan ST; Wong J
Clin Cancer Res; 2003 Nov; 9(14):5339-45. PubMed ID: 14614019
[TBL] [Abstract][Full Text] [Related]
26. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
27. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
[TBL] [Abstract][Full Text] [Related]
28. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever.
Tseng CS; Lo HW; Teng HC; Lo WC; Ker CG
FEMS Immunol Med Microbiol; 2005 Jan; 43(1):99-102. PubMed ID: 15607642
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
30. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
31. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
Dhar DK; Ono T; Yamanoi A; Soda Y; Yamaguchi E; Rahman MA; Kohno H; Nagasue N
Cancer; 2002 Nov; 95(10):2188-95. PubMed ID: 12412173
[TBL] [Abstract][Full Text] [Related]
32. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
[TBL] [Abstract][Full Text] [Related]
33. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
[TBL] [Abstract][Full Text] [Related]
34. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
Sun LX; Wu Y; Han HQ; Wang QH
Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
[TBL] [Abstract][Full Text] [Related]
35. [Serum levels of VEGF and nitric oxide in esophageal squamous carcinoma patients and the clinical significance].
Zhang T; Zhang F; Jiang T; Li XF; Wang YJ; Liu K
Ai Zheng; 2002 Nov; 21(11):1248-50. PubMed ID: 12526227
[TBL] [Abstract][Full Text] [Related]
36. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.
Li Q; Xu B; Fu L; Hao XS
J Exp Clin Cancer Res; 2006 Sep; 25(3):403-9. PubMed ID: 17167981
[TBL] [Abstract][Full Text] [Related]
37. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.
Sieghart W; Fellner S; Reiberger T; Ulbrich G; Ferlitsch A; Wacheck V; Peck-Radosavljevic M
Dig Liver Dis; 2009 Dec; 41(12):902-6. PubMed ID: 19501032
[TBL] [Abstract][Full Text] [Related]
38. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW
Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
[TBL] [Abstract][Full Text] [Related]
40. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma.
Yamaguchi R; Yano H; Nakashima O; Akiba J; Nishida N; Kurogi M; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):152-60. PubMed ID: 16706827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
